Acta Cardiologica Sinica

Acta Cardiologica Sinica is the bimonthly journal of the Taiwan Society of Cardiology, issued in Taipei since 1985 and indexed in the Science Citation Index Expanded since 2007.《心脏病学学报》（Acta Cardiologica Sinica）是台湾心脏病学会的双月刊，1985 年起在台北出版，2007 年进入科学引文索引扩展版。

Its 2025 Journal Impact Factor is 1.9 against a five-year figure of 1.7, which places it 151st of 237 titles in cardiac and cardiovascular systems.2025 年影响因子为 1.9，五年影响因子 1.7，在心脏与心血管系统类目 237 种刊物中列第 151 位。

Scope

• The society describes the remit as papers in every field connected with cardiovascular medicine, and it invites work that runs from bench measurement to ward practice.学会把收稿范围写作与心血管医学相关的一切领域，欢迎从实验室测量一直做到病房实践的研究。
• Basic research and vascular biology hold a standing place, with endothelial function, smooth muscle signalling and plaque biology among the subjects that recur.基础研究与血管生物学是常设板块，内皮功能、平滑肌信号与斑块生物学都属于反复出现的题材。
• Cardiovascular pharmacology is named in its own right, so drug mechanism studies and therapeutic trials sit inside the remit without needing a device or an imaging arm.心血管药理学单列一项，药物机制研究与治疗试验因此都在范围之内，不必附上器械或影像分支。
• General cardiology and epidemiology supply much of the volume, from risk-factor surveys to outcome analyses drawn from national registries.普通心脏病学与流行病学贡献了大部分篇目，既有危险因素调查，也有取自全台登记数据库的结局分析。
• Coronary artery disease and peripheral artery disease are handled together, since the same patient often carries calcification in both territories.冠状动脉疾病与外周动脉疾病放在一起处理，同一位患者常在两处血管都带钙化。
• Interventional cardiology and critical care medicine appear side by side, covering catheter techniques, haemodynamic support and the handling of cardiogenic shock.介入心脏病学与重症医学并列出现，涵盖导管技术、血流动力学支持与心源性休克的处置。
• Arrhythmia and electrophysiology form a large block, with ablation strategy, mapping and device therapy for pacing or defibrillation all inside the same section.心律失常与电生理构成一大块，消融策略、标测与起搏除颤的器械治疗都落在同一节内。
• Atherosclerosis, hypertension and preventive cardiology are grouped as the long-run subjects, where a cohort followed for a decade counts as a result in itself.动脉粥样硬化、高血压与预防心脏病学被归为长线题目，随访十年的队列本身就算一项结果。
• Cardiomyopathy, heart failure and pulmonary hypertension take the structural and haemodynamic end, including follow-up after transplantation and mechanical support.心肌病、心力衰竭与肺动脉高压承担结构与血流动力学那一端，移植与机械支持后的随访也在其中。
• Valvular and structural heart disease has grown with transcatheter techniques, and papers on valve selection, imaging before the procedure and durability now arrive regularly.瓣膜与结构性心脏病随经导管技术一同扩张，瓣膜选择、术前影像与耐久性研究如今定期到稿。
• Paediatric cardiology and cardiovascular surgery keep their own footing, so congenital lesions and operative series reach print beside adult clinical work.儿童心脏病学与心血管外科各有立足之地，先天性病变与手术系列因此与成人临床研究同期刊出。
• Cardio-oncology and multidisciplinary care have been added as the field widened, addressing cardiac risk from cancer therapy and the handover between specialties.肿瘤心脏病学与多学科协作随领域扩张被纳入，讨论抗癌治疗带来的心脏风险与科室之间的交接。
• Big data, artificial intelligence and digital health are invited as newer fields, an open door the editors keep for methods that have not yet settled into routine use.大数据、人工智能与数字医疗作为新兴领域被明确欢迎，编辑部为尚未进入常规使用的方法留着一扇门。
• Article types reach past the standard original, since protocols of registered trials, society guidelines or consensus statements and reviews of new topics are all accepted.体裁不止标准的原创论文，注册试验的方案、学会指南或共识声明与新题综述都在受理之列。

History

• The Taiwan Society of Cardiology formed in 1960 and now counts more than two thousand cardiologists among its active members, a body large enough to carry its own journal.台湾心脏病学会成立于 1960 年，现有两千余名活跃会员，规模足以支撑一份自办刊物。
• The journal began in 1985 as a quarterly, and volume 29 falling in 2013 fixes that starting point, since the run has advanced one volume a year throughout.刊物 1985 年以季刊起步，2013 年为第 29 卷这一点把起点钉住，因为全刊一直每年推进一卷。
• Twenty-eight years of quarterly issues ended in 2013, when the journal moved to six numbers a year, a change the National Library of Medicine records in its file.季刊延续 28 年，到 2013 年改为每年六期，美国国家医学图书馆的档案把这次改动作了记录。
• Indexing in the Science Citation Index Expanded began in 2007, and the first Journal Impact Factor arrived two years later at 0.253.科学引文索引扩展版的收录始于 2007 年，首个影响因子两年后给出，数值为 0.253。
• Growth since then has been steady rather than sudden, from 0.845 in 2014 to 0.927 in 2017 and 1.676 in 2018, before a peak of 2.672.此后的增长是渐进的，2014 年为 0.845，2017 年为 0.927，2018 年为 1.676，随后到达 2.672 的高点。
• The figure has since settled near 1.8 across several releases and stood at 1.9 in 2025, with a five-year value of 1.7 behind it.此后几个年度榜单都停在 1.8 附近，2025 年为 1.9，其后的五年影响因子为 1.7。
• The 2025 ranking puts the title 151st of 237 in cardiac and cardiovascular systems, a third-quartile place that the society states as a percentile of 63.7.2025 年的排名把它放在心脏与心血管系统类 237 种刊物的第 151 位，属第三四分位，学会给出的百分位是 63.7。
• PubMed coverage starts at volume 29, number 1, in 2013, so the quarterly years sit outside that database and have to be sought elsewhere.PubMed 的收录从 2013 年第 29 卷第 1 期开始，季刊年代的文章不进这一数据库，须另寻途径。
• Papers are deposited in PubMed Central, which puts the current volumes in front of readers who hold no subscription at all.论文存入 PubMed Central，现行各卷因此能被完全没有订阅的读者读到。
• Access stays with subscription for most papers, since gold open access covered only 0.58 percent of recent content, and the society sells the printed issues itself.多数论文仍靠订阅获取，近年内容里金色开放获取只占 0.58%，印本由学会自行销售。
• A year of the journal costs USD 60 for an individual and USD 48 for an institution, with single copies at USD 10 and air freight outside Taiwan adding USD 40.个人订费每年 60 美元，机构 48 美元，单本 10 美元，寄往台湾以外另加 40 美元航空邮费。
• About 57 research items appear in a typical year, and a cited half-life of 5.9 years means the recent volumes carry most of the citations.典型年份刊出约 57 篇研究文章，被引半衰期 5.9 年，说明引用主要落在近几卷。
• Volume numbers have run without a break from the first issue, which makes 2025 the 41st volume and puts the whole back file on a single sequence.卷号从首期起没有中断，2025 年因而是第 41 卷，全刊档案都排在同一条序号上。

Editors

• Yen-Wen Wu holds the editor-in-chief post, and the masthead also names a publisher, I-Chang Hsieh, who is president of the society at the same time.主编为 Yen-Wen Wu，刊头另列出版人 I-Chang Hsieh，他同时担任学会理事长。
• Ten deputy editors share the load, among them Shih-Lin Chang, Ching-Feng Cheng and Hung-Ju Lin.十位副主编分担审稿组织，Shih-Lin Chang、Ching-Feng Cheng 与 Hung-Ju Lin 都在其列。
• Executive editors number 34 and sit at hospitals across the island, a roster wide enough to cover every specialty the journal prints.执行编辑共 34 位，分布在台湾各地医院，名单覆盖面足以应付刊物所刊的各专业。
• A managing editor, Yuh-Ying Lin, and a statistician, I-Fan Lin, complete the office, so the numbers in an accepted paper get a second look before typesetting.编辑部另设编辑主任 Yuh-Ying Lin 与统计编辑 I-Fan Lin，录用论文里的数字在排版前会再过一遍。
• Manuscripts go through ScholarOne at mc04.manuscriptcentral.com/acstsoc, the account the society keeps open for submissions and revisions.稿件经 ScholarOne 提交，入口为学会为刊物开设的 mc04.manuscriptcentral.com/acstsoc 账户。
• Authors download the copyright assignment and the instructions from the society site before starting, so the formalities are settled ahead of review.作者动笔前先从学会网站下载版权转让书与投稿须知，投稿清单也在同一页，形式要件在送审前就已办妥。
• Submissions arrive from more than thirty countries, and the society reports that 39 percent come from Turkey, 27 percent from China and 22 percent from Taiwan.来稿来自三十多个国家，学会统计其中 39% 出自土耳其，27% 出自中国，22% 出自台湾。
• The stated goal is to make the title the leading cardiology journal in Asia, a line the society prints on its journal pages.学会把目标写成让本刊成为亚洲领先的心脏病学杂志，这句话直接印在刊页上。
• Reviews of novel topics and society consensus statements pass the same editors, which keeps guidelines and primary research under one editorial standard.新题综述与学会共识声明由同一批编辑过手，指南与原始研究因此共用一套编辑标准。
• The editorial office sits at 13F-1, No. 11, Min-Chuan W. Rd. in Taipei, the address the society prints at the foot of its journal pages rather than a publisher's inbox abroad.编辑部设在台北市民权西路 11 号的 13 楼之 1，这一地址印在学会刊页的页脚，信件不走境外出版方的信箱。
• The society keeps a separate desk for subscriptions and single copies, so orders for the printed issues never enter the manuscript queue.学会为订阅与单本零售另设窗口，印本的订单不会进入稿件队列。